Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, read about six advances in bowel cancer, apply for a PhD studentship or watch our researchers highlight industry interactions.

Can we cure cancer? Nine challenges scientists say we need to overcome

Our Head of Content and Partnerships, Henry French, introduces some of the issues that cancer researchers are considering in the search for cancer cures.
Read more
Targeted breast cancer drug – olaparib – given green light by EU

European Medicines Agency approves olaparib for women with BRCA-mutant breast cancer – 15 months after licensing in the US.
Read more
Cancers ‘change spots’ to avoid immunotherapy

Cancers can make themselves harder for new immunotherapies to see by ‘changing their spots’ – and switching off a key molecule on the surface of cells that is otherwise recognised by treatment.
Read more
Sign up for the 2020 London Landmarks Half Marathon

During April, get your Early Bird discount for the London Landmarks Half Marathon – the quirkiest race in London! Secure a place for only £17.50.
Sign up
How we work with industry

The Enterprise Unit acts as the technology and knowledge transfer hub for The Institute of Cancer Research, providing the experience and expertise to put in place a wide range of agreements between our scientists and industry.
Read more

1/5

Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more
Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more